Related Experiment Videos
Early parenteral corticosteroid administration in acute asthma
R Y Lin1, G R Pesola, R E Westfal
1Department of Medicine, St Vincent's Hospital, New York, NY 10011, USA.
The American Journal of Emergency Medicine
|December 31, 1997
Summary
Early corticosteroid treatment did not significantly improve airflow obstruction in adult asthma patients within the first hour. Further research is needed for rapid bronchodilation therapies in acute asthma management.
Area of Science:
- Pulmonology
- Emergency Medicine
- Clinical Pharmacology
Background:
- Acute asthma exacerbations require prompt and effective treatment to relieve airflow obstruction.
- The role of early parenteral corticosteroid administration in rapidly improving asthma symptoms is not fully established.
Purpose of the Study:
- To evaluate the hypothesis that early intravenous methylprednisolone administration improves airflow obstruction in adult asthma patients within one hour.
Main Methods:
- A randomized, double-blind, placebo-controlled study involving 45 adult asthma patients with severe airflow obstruction (PEFR < 200 L/sec).
- Patients received either intravenous methylprednisolone (MP) or saline, followed by three albuterol aerosol treatments.
- Peak expiratory flow rates (PEFRs) and heart rates were monitored for one hour.
Main Results:
- No significant difference in the rate of PEFR increase was observed between the methylprednisolone and saline groups.
- The saline group showed a trend towards a higher rate of increase in percent PEFR (P = .061).
- Hospitalization rates and side effects did not differ significantly between groups.
Conclusions:
- Early parenteral corticosteroid administration does not appear to provide rapid bronchodilatory benefits within the first hour of treatment for acute asthma.
- Further investigation into rapid-acting bronchodilator modalities is warranted for acute asthma management.